1 ratings / 4 average

Treatment Strategies

Stelmasiak Z, Solski J, Nowicki J et al.

Medical University of Lublin, Lublin, Poland.

 Mult Scler 2009;15:767–70.

Editor’s note: Several studies have reported the potential of cladribine as a disease-modifying drug in multiple sclerosis (MS). Cladribine is a purine nucleoside analogue that reduces lymphocyte counts in a preferential manner (in particular CD4+T cell count).

Return to top

LATEST ARTICLES